Live Breaking News & Updates on Sierra Eye Associates

Stay updated with breaking news from Sierra eye associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

ZUG, Switzerland, May 30, 2024 Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members. ....

United States , California Institute Of Technology , San Diego , Nordrhein Westfalen , City Of , United Kingdom , Baden Wüberg , United Kingdom General , Arshadm Khanani , Ronald Michels , Corey Davis , Frankg Holz , Anthony Rosenberg , Sylvia Cheung , Baruchd Kuppermann , Robertk Warner , Robert Glaser , Christina Ackermann , Martijn Kleijwegt , Geraldine Okeeffe , University Of Heidelberg , Member Of The Club Jules Gonin , Exchange Commission , Alcon Research Institute , University Of Nevada , Retina Society ,

4DMT Announces Presentations at ARVO 2024 Annual Meeting

Preclinical data for 4D-175 for geographic atrophy to be presented in an oral presentation4D-150 PRISM randomized Phase 2 Dose Expansion Cohort 24-week encore results to be presented in a poster . ....

United States , Melissaa Calton , Julian Pei , Arshadm Khanani , Katherine Smith , Stage Product Development , Clinical Associate Professor At University Of Nevada , Clinical Research At Sierra Eye Associates , Association For Research , Reno School Of Medicine , Expansion Cohort , Molecular Therapeutics , Annual Meeting , Meeting Presentation Details , Clinical Research , Sierra Eye Associates , Clinical Associate Professor , Reno School , Early Stage Product Development , Scientific Presentations , Therapeutic Vector Evolution , Nobel Prize Winning , Investor Relations ,

Opthea : Quarterly Activity Report - Form 6-K

Quarterly Activity Report

Q3 FY24

Highlights

•

Completion of enrolment in first trial of sozinibercept s Phase 3 pivotal program. ....

United States , Julie Clark , Xand Linkedin , Arshad Khanani , Silvana Guerci Lena , Arshadm Khanani , Fred Guerard , Astellas Company , Genentech United States Inc , Fellowship At Sierra Eye Associates , Exchange Commission , Leadership Team , University Of Nevada , Clinical Development , Drug Administration , Lomb Corporation , Reno School Of Medicine , Exchange Commission On , Sierra Eye Associates , Development Funding Agreement , Clinical Research , Roche Group , Regulatory Affairs , Alcon Inc , Opthea Limited , Quarterly Activity Report ,

Opthea highlights latest phase 3 trials for sozinibercept

The molecule is being evaluated in 2 phase 3 clinical trials for wet AMD and is administered via intravitreal injection in combination with standard-of-care anti–VEGF-A therapy. ....

United States , University Of Nevada , Charlesc Wykoff , Arshadm Khanani , Veerals Sheth , Reno School Of Medicine , University Retina , University Of Illinois At Chicago , Blanton Eye Institute , Sierra Eye Associates In Reno , Macula Associates , American Society Of Retina Specialists , Image Credit , Sierra Eye Associates , Reno School , Retina Consultants , Houston Methodist Hospital , Trends Survey , American Society , Retina Specialists ,

RESTORE: MCO-010 Achieves Significant Vision Restoration in Retinitis Pigmentosa

The phase 2b trial showed a statistically significant improvement of BCVA at week 52 in both the high-dose and low-dose MCO-010 cohorts compared with sham. ....

United States , David Boyer , Arshadm Khanani , Reno School Of Medicine , Drug Administration , University Of Nevada , Sierra Eye Associates , Nanoscope Therapeutics , Biologics License Application , Reno School , Southern California Keck School ,